Procurement Summary
Country: Brazil
Summary: Medicines on Demand
Deadline: 24 Jun 2026
Posting Date: 15 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143327349
Document Ref. No.: 91021/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Medicines on Demand UASG code: 250105 Notice from: 06/15/2026 from 09:00 to 12:00 and from 13:00 to 15:00 Proposal Delivery: from 06/15/2026 at 09:00 APALUTAMIDE, CONCENTRATION 60 MG Quantity: 10599 AXITINIB, CONCENTRATION 5 MG Quantity: 1298 AZACITIDINE, CONCENTRATION 100 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 405 BRENTUXIMAB VEDOTIN, CONCENTRATION 50 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 21 cetuximab, CONCENTRATION 5 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 960 CYCLOSPORINE, CONCENTRATION 100 MG Quantity: 8736 CLADRIBIN, CONCENTRATION 1 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 36 PROTHROMBINIC COMPLEX, HUMAN TYPE, ACTIVITY 500 IU, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION + DILUENT Quantity: 8 DARATUMUMAB, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 50 DARATUMUMAB, CONCENTRATION 120 MG/ML, PHARMACEUTICAL FORM SOLUTION INJECTABLE Quantity: 27 DARATUMUMAB, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 36 DENOSUMAB, CONCENTRATION 60 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 24 ENZALUTAMIDE, CONCENTRATION 40 MG Quantity: 3802 COAGULATION FACTOR CONCENTRATE, FACTOR I FACTOR (FIBRINOGEN), CONCENTRATION 1 G, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 4 FOSAPREPITANTO DIMEGLUMINE, CONCENTRATION 150 MG, PHARMACEUTICAL FORM LYOPHILOP/ INJECTABLE POWDER Quantity: 50 GEFITINIB, CONCENTRATION 250 MG Quantity: 720 INDACATEROL MALEATE, COMPOSITION ASSOCIATED WITH GLYCOPIRRONUM, CONCENTRATION 110 MCG + 50 MCG, PHARMACEUTICAL FORM CAPSULE INHALER POWDER, ADDITIONAL CHARACTERISTICS WITH INHALER Quantity: 2160 ASPARAGINASE, DOSAGE 10, 000UI, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 50 L...
Documents
Tender Notice